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ABSTRACT 
Dengue fever has reemerged as a serious public health issue worldwide. The disease is 
endemic in more than 100 countries, with an estimated 50-100 million cases annually. It is 
considered endemic to Cambodia and, despite multiple control programs, the country has 
10,000-40,000 hospitalized cases per year for children less than 15 years of age. In order to have 
control approaches that are more effective, the patterns of dengue cases in Cambodia need to be 
further explored. This study seeks to clarify the patterns of dengue by performing a geospatial 
analysis of 11 years of national surveillance data, from 2002 to 2012. Various exploratory 
geospatial statistical tools were used to calculate the local indicators of spatial autocorrelation 
and the local Gi* statistic analysis to determine significant hot and cold spots of dengue fever at 
the district level of Cambodia. Results found that in most years between 2002 and 2012, the two 
urban centers of Cambodia, Phnom Penh and Siem Reap, were significant hot spots for dengue 
fever. This suggests that prevention and control programs should be targeted to these two areas 
specifically. However, these clusters corresponded with five of the seven sentinel surveillance 
sites used in the country. This analysis could be only a representative of more sensitive 
surveillance. Expanding sentinel surveillance activities to other provinces could reveal a clearer 
picture of dengue fever in Cambodia.  
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1.0  INTRODUCTION 
Vector-borne infectious diseases account for about 17% of the global burden of all 
infectious diseases[1]. These diseases include: malaria, yellow fever, West Nile virus, dengue 
fever, plus many more. Despite the control efforts for mosquito-borne illnesses, malaria, West 
Nile virus and dengue fever have reemerged as serious public health issues in tropical and sub-
tropical countries. Dengue fever is one the fastest growing vector-borne diseases, with a drastic 
increase of cases in the last two decades [1]. The disease is endemic in more than 100 countries, 
with an estimated 50-100 million cases annually [2]. Dengue is considered endemic to Cambodia 
and, despite multiple control programs, the country still has 10,000-40,000 hospitalized cases per 
year for children less than 15 years of age [3]. In order to have control and prevention 
approaches that are more effective, the patterns of dengue cases in Cambodia should be explored. 
This study examines eleven years of dengue fever surveillance data from Cambodia for 
incidence and spatial-temporal patterns. These patterns should reveal where the most, and least, 
dengue cases occur in Cambodia and assist in targeting control and prevention activities.    
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2.0  BACKGROUND 
2.1 DENGUE FEVER 
Dengue fever is a mosquito-borne viral infection that has affected tropical and sub-
tropical countries since the 18th and 19th centuries [4]. The primary mosquito vector is the female 
Aedes aegypti, which passes the virus to humans. The Aedes aegypti breed mostly in man-made 
water containers, such as large jars that catch rain water. The Ae. aegypti is distinct in that it 
feeds during the day, peak time being early in the morning and just before dusk. They also can 
bite multiple people during feeding time [5].  
There are four different serotypes of the dengue virus (DENV), DENV-1, DENV-2, 
DENV-3 and DENV-4 [5]. If a person is infected and recovers from one serotype, they would 
have lifelong immunity against that one serotype. There is some partial immunity to the other 
serotypes, but this is only temporary. Infection with multiple serotypes or consecutive infection 
with a different serotype can increase the risk of developing more severe dengue [5].  
The case fatality rate of dengue varies by region and country, but is usually around 1% or 
less, though some areas have rates as high as 5% [5, 6]. Dengue causes severe flu-like symptoms, 
including a high sustained fever, headache, severe joint pain and rash. These symptoms can last 
between two and seven days, after the four to ten day incubation period from the bite of an 
infected mosquito [7]. A person can be infected with the virus but present with no symptoms. 
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The United States Centers for Disease Control and Prevention (CDC) reports that, “as many as 
one half of all dengue infected individuals are asymptomatic…” [8]. Dengue hemorrhagic fever 
(DHF) is the more severe, and sometimes fatal, form of dengue. DHF causes plasma leaking, 
fluid accumulation and respiratory distress. Symptoms include vomiting, bleeding gums, fatigue 
and severe abdominal pain. Immediate medical care is necessary for DHF cases. There is 
currently no cure or vaccine for any serotype of dengue fever. If caught early, fluid replacement 
is most effective [5].   
2.1.1 DISEASE BURDEN 
More than 100 tropical countries have endemic dengue infections and DHF has been 
reported in more than 60 of these countries. It is considered endemic in the Americas, Southeast 
Asia, Western Pacific, Africa and Eastern Mediterranean. Of these, the Americas, Southeast Asia 
and Western Pacific carry the heaviest burden [2]. In the past 20 years, global reports of DHF 
have increased fivefold [4].  
According to the World Health Organization [5] data, the average number of dengue 
fever/dengue hemorrhagic fever cases per year has risen from 908 between 1950 and 1959 to 
nearly 515,000 between 1990 and 1999. It is estimated that the real numbers are closer to 50 
million cases a year, causing 24,000 deaths [9].  
There are an estimated 2.5 billion people in the world at risk for dengue and about 70% 
of that number live in Asia Pacific countries [10]. This places a large burden on the region. In 
Southeast Asia dengue has been shown to have a significant economic and disease burden for the 
area. Shepard et al. conducted an analysis of the economic and disease burden of dengue in 
twelve Southeast Asian countries [11]. The study found an annual cost per capita of $1.65 and a 
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disease burden of 372 Disability Adjusted Life Years (DALYs) per million persons. This rate is 
higher than Japanese encephalitis, upper respiratory infections and hepatitis B [11]. Clearly, 
dengue fever is a growing public health issue. 
2.1.2 RESURGENCE OF DENGUE FEVER 
The resurgence of dengue fever in the last 20 years could be attributable to increases in 
the geographic distribution of the Ae. agyepti mosquito and in the rate and geographic range of 
virus transmission [2]. Rapid global population growth and unplanned urbanization have resulted 
in substandard housing, inadequate water supply and waste management systems, which provide 
the vector with additional breeding grounds. An increase in air travel has allowed different 
strains, serotypes and genotypes to be introduced into other regions [2]. 
2.1.3 SURVEILLANCE  
Dengue fever surveillance is key to having effective prevention and control program, 
however in most endemic countries, the surveillance systems are lacking. Estimates from many 
countries have been found to be consistently lower than what sample studies have shown. In 
1996, the Laos surveillance system reported 2563 DHF cases, while the WHO reported 8197 
cases [9]. In Indonesia, an evaluation found that only 31% of hospitalized DHF/Dengue Shock 
Syndrome (DSS) cases were actually reported to the appropriate authorities [9]. The WHO, in 
2004, estimated there were 0.5 million DHF cases, but if underreporting studies are taken into 
account, the global incidence rate could have actually been around 1.5 million cases of DHF [9]. 
Most of these surveillance systems are passive in nature, meaning hospitals or health centers are 
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responsible for reporting dengue cases through the government system. Guha-Sapir and 
Schimmer suggest implementing more sentinel, or active, surveillance to provide more accurate 
estimates of disease burden, as well as sampling of the private sector [9]. 
As of February 2013, there were five dengue vaccine candidates in different clinical 
phases [12]. This includes one in Phase III and two in Phase II testing. The most promising is a 
live attenuated chimeric tetravalent vaccine developed by Sanofi Pasteur, which underwent 
Phase IIb testing in Thailand and results were published in 2012 [13]. Results of this study found 
the vaccine was safe, with little to no side-effects and had an efficacy of 30.2% [13]. As a safe 
and efficacious vaccine is completed, surveillance will play a significant role in determining 
where to distribute the vaccine. 
2.1.4 PATTERNS OF DISEASE TRANSMISSION 
There are several factors that can affect the transmission of dengue fever. These include 
environmental, particularly climate change, human and vector behaviors, virulence of the four 
strains and immunity of human hosts [14]. Liebman et al. conducted a spatial dimensions study 
of dengue transmission in Iquitos, Peru from 1999 to 2003 and found that seroprevalance of the 
previously circulating DENV serotype can be a predictor of transmission risk for a different 
infecting serotype. The study also found that regardless of serotype, human movement is an 
important factor in defining the spatial dimensions of DENV transmission, as well as mosquito 
population [15]. Due to the fact that human movement and vector population can contribute to 
the spread of the dengue virus, spatial patterns of dengue are important to examine. Through 
examination of these transmission patterns, officials could identify where surveillance and 
interventions could be targeted to prevent or reduce further outbreaks [15]. 
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The relationship between dengue fever in urban and rural areas is not completely 
understood. The virus has most commonly been thought of as an urban disease with cases 
originating in urban centers and spreading into the rural areas of a country [9]. However, recent 
studies have shown varying sources of dengue epidemics, including an increase of dengue in 
rural areas of Thailand and India [16-18]. In 1998, Thailand had a higher incident rate in rural 
areas compared to urban areas [16]. An increase in dengue fever among rural populations has 
also been seen in Central and South America [19]. Urbanization and increased transportation 
could be a potential reason for this spread of dengue to rural areas [20]. 
2.1.5 PREVENTION, CONTROL AND OUTBREAK RESPONSE  
Until there is a vaccine available for prevention of dengue fever, vector control is the 
primary way to reduce dengue transmission [6]. This has proven difficult, as most endemic 
countries are considered low-income and lack the financial resources to sustain control 
programs. Guzman suggests the following principles must be present for effective dengue 
control: political will, improvement of public health infrastructure and vector control programs, 
inter-sector coordination, active community participation and reinforcement of health legislation 
[2]. Of these, she notes it is essential that the community accepts responsibility in dengue control 
[2].   
Early detection and case management are two other methods for dengue prevention and 
control [9]. These are particularly important in decreasing DHF/DSS mortality rates. However, 
in many endemic countries patients must travel long distances to reach a health facility, and most 
times that facility is not equipped with a laboratory to confirm the dengue diagnosis. Overall 
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strengthening of health systems is needed to improve both early detection and case management 
of dengue [9].  
Thailand’s patterns of dengue are cyclic in nature, meaning epidemics occur every few 
years, in this case every four to five years [21]. Barbazan, Yoksan and Gonzalez completed a 
study in 2001 that described and forecasted epidemics of dengue in Thailand [21]. The authors 
suggested that early detection of epidemics through a local case detection network would be 
ideal; however they recognized the financial and human resource burden this could entail. In 
addition, they recommended that the efficiency of control programs would be improved by 
defining the highest risk areas within provinces, which can be located through spatial analysis 
[21].   
2.2 CAMBODIA 
Cambodia is a country in Southeast Asia with a population near 15 million in 2012 [22]. 
It is bordered by Thailand to the west, Laos to the north, Vietnam to the east and the Gulf of 
Thailand. The country is characterized as agricultural and tropical, with a distinct monsoon 
season from May to October. Geographically, Cambodia contains 24 provinces, 185 districts, 
362 communes and over 13,000 villages. Phnom Penh is the capital city, where about 20% of the 
population resides [23].   
The overall health of Cambodia has been improving in the past decade as the country has 
developed. Infant mortality has dropped a third from 2005 to 2010, the under-five mortality rate 
also dropped significantly during the same time period [24]. The life expectancy at birth has 
increased to nearly 71 years in 2012 from 66 in 2004 [22]. The fertility rate has steadily declined 
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from 3.4 births per woman in 2005 to about 2.6 births in 2013, though the rate is slightly higher 
in rural areas compared to urban [23, 24]. 
According to the 2010 Global Burden of Disease Study, Cambodia ranked third for 
health-adjusted life expectancy and fifth for age-standardized death rate per 100,000 when 
compared to similar countries. Compared to 1990, where the top three causes of mortality in 
terms of Years of Life Lost (YLL) were lower respiratory infections, diarrheal diseases and 
malaria, in 2010 the top three causes of YLL were lower respiratory infections, ischemic heart 
disease and cerebrovascular disease [25].  
2.2.1 DENGUE FEVER IN CAMBODIA 
In Cambodia, according to the 2010 Global Burden of Disease Study, dengue fever rose 
from the 29th cause of YLL for those under five, to 22nd from 1990 to 2010. It also rose for those 
between five and fourteen years of age in the same time period, from 19th to 13th in overall 
causes of YLL [26].  
In Cambodia, the national data has shown high incidences in both rural and urban areas. 
A study of cases between 2006 and 2008 in Kampong Cham province of Cambodia that used 
community-based active surveillance, found that rural areas were typically affected by dengue to 
the same degree as urban areas [14]. Possible factors that could explain the high urban and rural 
rates include, rapid human growth and the lack of improved sanitation leaving more man-made 
water containers for vector breeding [14]. Vong et al. also cited that the majority of the rural 
villages in the study were located near a national roadway, which had frequent and regular traffic 
from the capital, which could allow dengue introduction from infected individuals passing 
through the area [14]. 
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Most dengue control programs in Cambodia are focused on vector control. Larvacide 
campaigns are typically done twice a year, between April and July and between August and 
October. The NDCP targets water storage containers in the more populated areas and urban 
centers. They also provide education to the public through various education campaigns, 
including commercials that are aired countrywide [27].    
Abate distribution is a common preventive measure taken in Cambodia as well. An 
ethnographic study of two villages in Kampong Cham Province was conducted in 2007 to 
describe the public knowledge of the vector, what practices were used to reduce breeding sites 
and if the distribution of Abate was successful [28]. During the time of the study, Abate was only 
used during the rainy season, despite water containers testing positive for larvae in the dry 
season. The study found that various unused water containers contained twice the number of 
larvae as used water storage containers, but these were not targeted for Abate distribution. The 
authors recommended that the reliance on Abate should be reevaluated, particularly its 
distribution to more affected water storage containers [28]. 
Khun and Manderson also completed a process evaluation of community and school-
based health education for dengue control in rural Cambodia [29]. Dengue control is taught in 
primary schools, health centers and by the NDCP in Cambodia. The evaluation of this education 
found that there is no routine evaluation of the educational programs, messages can be confusing 
and health staff and teachers do not have the training, time or opportunity to deliver the 
education [29]. While the authors found that school children and their parents were familiar with 
the Aedes agyepti mosquito and the environmental factors that contribute to dengue, this 
knowledge was rarely translated to reducing to the risk of infection [29].  
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2.2.2 DENGUE SURVEILLANCE IN CAMBODIA 
The initial surveillance system of Cambodia was passive, meaning hospitals and health 
centers were responsible for reporting cases of dengue to the Ministry of Health. This type of 
surveillance in Cambodia began in 1980. The National Dengue Control Program (NDCP) was 
created in 1996 and has been responsible for dengue fever surveillance in the country ever since 
[30]. The passive system was supplemented in 2001, when the NDCP implemented an active 
sentinel surveillance system to try to capture more dengue cases. This system started with three 
public hospitals and three private hospitals in four provinces. There are now seven hospitals in 
the sentinel system, representing four provinces. The NDCP actively records the number of 
dengue fever cases from these particular hospitals on a weekly basis [31].  
It is important to discuss the clinical case definition used in reporting dengue fever cases 
in Cambodia. Since 2002, cases have been based on the World Health Organization definition. 
The WHO definition is as follows: 
Probable case-an acute febrile illness with two or more of the following: headache, retro-
orbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, or leukopenia and 
supportive serology or occurrence at the same location and time as other confirmed cases 
of dengue fever.  
Laboratory confirmed by: isolation of dengue virus, detection of dengue virus RNA in 
serum or tissues and detection of specific dengue virus antigen; through serum samples 
by haemagglutination-inhibition, complement fixation, neutralization test, IgM-capture 
enzyme-linked immunosorbent assay or indirect IgG ELISA. 
Reportable case-any probable or confirmed case should be reported [32]. 
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According to the Standard Operating Procedure manual of the NDCP, the definition to be used 
by hospitals and health centers in suspected dengue cases is: An acute febrile illness of 2-7 days 
duration with two or more of the following manifestations: headache, retro-orbital pain, muscle 
and joint pain, rash, hemorrhagic manifestations (positive tourniquet test, petechiae, etc.). All the 
suspected dengue cases (all ages and both gender) must be referred to a referral hospital for 
medical observation and monitoring [30].   
As a person can be infected with dengue, but present with no symptoms, virological and 
serological testing is needed to confirm an actual dengue fever infection. Lab testing is also the 
only way to determine the virus serotype. However, due to limited resources in Cambodia, 
serological testing is only completed at five of the sentinel surveillance sites [31]. Additionally, 
both the active and passive surveillance systems only collect hospitalized cases of dengue. This 
fact along with the lack of lab confirmations could potentially be underestimating the burden of 
dengue fever in Cambodia.  
A capture-recapture analysis was done between 2006 and 2008 in Cambodia [3]. The 
study used community-based active surveillance in Kampong Cham Province, the largest 
province, to determine dengue under-recognition of the national surveillance system. Results of 
this study found an incidence of dengue between 13.4 and 57.8 per 1,000 person-seasons 
(persons infected during dengue season, not year round) while the national surveillance data 
reported an incidence between 1.1 and 5.7 per 1,000 person-seasons for the same time period. 
Due to the national surveillance system only reporting on hospitalized cases, the NDCP is likely 
missing a large proportion of less severe dengue fever [3]. Currently, there are several dengue 
fever vaccines being developed and put through clinical trials, as a vaccine becomes available, 
surveillance will become a vital factor in its distribution [12]. 
 11 
3.0  METHODS 
District level data was provided by the National Dengue Control Program of the Ministry 
of Health in Cambodia and was deemed exempt from human subjects research by the University 
of Pittsburgh Institutional Review Board.  
3.1 DATA  
Dengue fever cases between 2002 and 2012 were reported both passively and actively on 
a weekly basis to the NDCP using the WHO case definition discussed earlier. This study used 
the aggregate number of cases per district per month for analysis. Population data for years 2002 
through 2012 was also provided by the NDCP, which are national census numbers. Population 
figures were made available for provinces and districts of each year. 
Yearly provincial incidence was calculated by dividing the number of annual cases by the 
total population and then multiplied by 100,000. This was also done for the provincial and 
district levels. Monthly incidence was determined similarly at the provincial and district level. 
Histograms of incidence by month were created to visualize yearly trends of dengue fever at the 
two separate administrative levels.  
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3.2 GEOSPATIAL ANALYSIS 
Multiple geographic information systems were used to analyze and visualize the data. 
GeoDa and Crime Analytics for Space-Time, both of which are open-source software programs 
available from the GeoDa Center for Geospatial Analysis and Computation from the University 
of Arizona [33]. These programs, along with ArcGIS, were used to map clusters and perform 
spatial-temporal analysis for this study. Country, Provincial and District shapefiles were obtained 
from the Global Administrative Areas website [34]. Shapefiles were downloaded for Cambodia 
for all administrative layers.  
Spatial-temporal analysis was completed using CAST for years 2002 to 2012 at the 
district level. Gi* cluster analysis was done to show if there was clustering of high or low values 
of dengue fever around one location. The null hypothesis is there is no clustering of high or low 
values around location i, the test statistic is close to zero and the alternate hypothesis is there is 
clustering of high or low values around location i; a significant positive value implies a 
clustering of high values and a significant negative value indicates a clustering of low values. 
The formula is shown below, where x jt are the values of a variable observed at location j and 
time t. These values are multiplied by the spatial weights set, wij, which denotes the locations to 
include in the analysis and how to weight them. A Queen weight was used in this analysis, which 
means all districts sharing any boundary point are considered neighbors. The sum of these 
observed values is subtracted from the expected value, the sample mean, multiplied by the sum 
of the weights. Finally, this difference is divided by the standard deviation.  The Gi* statistic is a 
Z-score. The significance of each Gi* value is done using a Monte Carlo randomization of the 
dataset. A large, positive Z score means there is clustering of high values, or a hot spot, and a 
small, negative Z score means clustering of low values, or a cold spot [35]. 
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Local Indicators of Spatial Autocorrelation (LISA) identifies the association between an 
observation and its neighbors by using the local Moran’s I statistic and classifies the 
observations, as shown in Table 1. Neighbors were defined as the districts that shared any 
boundary with the district being analyzed. The average of the local Moran statistic is 
proportional to the Global Moran’s I value. Local Moran’s I formula is below; wij is the spatial 
weight between i and j, n is the number of observations, xi is an attribute for feature i, X bar is the 
mean of the corresponding attribute [36]. The results are similar to Gi*, as a Z score is 
calculated, but LISA also calculates a p-value for significance. A positive value for I means a 
feature has neighboring features with similar values and is considered part of a cluster. A 
negative I value means that a feature has neighbors with dissimilar values and is considered an 
outlier. A p-value of 0.05 is used to determine the statistical significance [37].  
 
 
Table 1. LISA Classifications 
 
 Classification Meaning 
High-High High values surrounded by high values-considered hot spots 
Low-Low Low values surrounded by low values-considered cold spots 
Low-High Low values surrounded by high values-potential spatial outliers 
High-Low High values surrounded by low values-potential spatial outliers 
 14 
4.0  RESULTS 
4.1  DESCRIPTIVE 
Between 2002 and 2012, Cambodia reported 192,128 cases of dengue fever. The annual 
incidence of dengue ranged from 70.77 to 311.99 per 100,000, with the highest in 2007 and 
lowest in 2005; refer to Table 2 and Figure 1 below. 
Table 2. Total Incidence by Year 
Figure 1. Total Incidence by Year 
Year Incidence per 100,000 
2002 102.132 
2003 98.3708 
2004 78.157 
2005 70.774 
2006 130.345 
2007 311.994 
2008 69.634 
2009 80.381 
2010 88.983 
2011 111.099 
2012 287.615 
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 When annual incidence is visualized by month and year, Figure 2, the highest incidence 
rates occur between May and August for all years. Two epidemic years can be seen, in 2007 and 
2012, where the rates were nearly three times of that in non-epidemic years. June and July were 
the peak months of incidence for all years except 2006, which peaked in August.  
Figure 2. Incidence by Month and Year 
 
Figure 3 illustrates the yearly incidence per 100,000 of dengue fever in each province. 
Again, the highest incidences are seen in the 2007 and 2012 epidemic years. In 2007, Kandal, 
Phnom Penh, Siem Reap and Takeo recorded the highest incidence. In 2012, Banteay Meanchey, 
Kandal, Siem Reap, and Oddar Meanchey were the highest.  
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Figure 3. Incidence by Province and Year 
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4.2 GEOSPATIAL ANALYSIS 
All maps referred to in this section are located in Maps appendix.  
Figures 5-7 are Local Gi* cluster and significance maps for each year, 2002 to 2012. 
Phnom Penh reveals high-high clustering for all eleven years, with significant p-values ranging 
from 0.05 to 0.001. Districts within Siem Reap Province also show high clustering in all years 
except 2004, 2005 and 2006. The northeast and southwest regions for all eleven years show low-
low clustering, but that the clusters are significant at the 0.05 and 0.01 p-values meaning there is 
clustering of low values around those locations. 
The LISA maps are shown in Figures 8 and 9 for each year. These map results are 
classified as those shown in Table 1. These show similar results to the Local Gi* maps, in that 
Phnom Penh and Siem Reap both have high-high clustering, considered to be hot spots of dengue 
fever, and the northeast and southwest regions have low-low clustering, representing cold spots 
of dengue. The 2004 map revealed Sandan District in Kampong Thom Province, had high-low 
clustering. This represents a potential spatial outlier. In 2005, high-low clustering is seen in two 
districts and low-high in two districts in the northwest region of the country.   
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5.0  DISCUSSION 
The incidence by month results, Figure 2, in this study, support other analyses in that the 
majority of dengue cases in Cambodia occur between May and August, which corresponds to the 
country’s monsoon season when there are more breeding sites for the vector [31, 38, 39]. Two 
epidemic years were identified from this study, in 2007 and 2012. Again, this supports other 
studies that have shown dengue fever is cyclic in nature, causing epidemics every four to five 
years in most endemic countries [11, 14, 40]. The 2007 epidemic has been examined by other 
studies, however the 2012 data in this study is recent enough that the author was unable to find 
studies that analyzed data from this year.  
The local Gi* maps, Figures 5-7, display significant hot and cold spots for dengue at the 
district level. Over the eleven years, Phnom Penh was consistently a significant hot spot for 
dengue cases. The districts surrounding the capital city were also significant each year. 
Significance for hot spots means that the neighbors surrounding the district that was analyzed all 
contained high numbers of dengue fever cases and this could not occur by chance. These hot spot 
results would promote the use of prevention programs targeted to Phnom Penh and the 
surrounding districts.  
The northeast and southwest regions of Cambodia were regularly cold spots for dengue 
cases. The northeast region of Cambodia is considered to be very poor, rural and, notably, 
dependable roadways to that area were only just completed in 2008 [27]. Because of the 
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remoteness of this area, surveillance activities could be decreased or absent for many of the 
districts. Likewise, the southwest region of Cambodia is considered rural and has unreliable 
roads and transportation from the more populated areas of the country. Inhabitants of these 
regions are less likely to seek medical care in a health center or hospital, where dengue can be 
identified, simply because there is not a health facility nearby. However, the isolation could be 
the reason for the low numbers of dengue fever as well. With one of the lowest populations in 
the country and little traffic in and out of these provinces, people are not bringing in the virus or 
the vector is not being transported from high risk areas, such as Phnom Penh.  
Siem Reap Province was similar to the Phnom Penh area, with consistent hot spots each 
year. The districts within Siem Reap, however, varied in significance from year to year. For 
example, from 2004 to 2006 no districts had significant hot or cold spots. Siem Reap contains 
two of the sentinel surveillance sites, which provides more accurate and timely data to the 
NDCP. This is likely an accurate picture of dengue in Siem Reap Province. Since the majority of 
the years examined in this study, showed significant hot spots for districts in Siem Reap, 
prevention and control programs should be targeted here as well. 
Phnom Penh and Siem Reap were both consistently hot spots for dengue fever at the 
district level. This was expected as population density is higher and five of the sentinel 
surveillance sites are located in these two areas, as seen in Figure 4. With sentinel sites, 
surveillance is likely more sensitive and the analysis maps could simply be representative of the 
active surveillance at those sentinel locations.   
Unexpectedly, Battambang Province and Banteay Meanchey Province both had 
significant hot spots nine out of the eleven years analyzed. This could due to traffic between 
Siem Reap and Battambang, both of which are heavily populated and transport centers for the 
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rest of the country. Battambang Province to Banteay Meanchey Province is also the predominant 
route of those traveling to and from Thailand. This raises the question of whether the dengue 
viruses are being transported from Thailand into Cambodia or vice versa. Unfortunately, this 
goes beyond the scope of this study, but leaves an area that needs to be explored further. Of note, 
the United States Center for Disease Control and Prevention  has been funding the improvement 
of Cambodia’s TB, HIV, and influenza surveillance systems, as well as supporting the national 
communicable disease surveillance, of which contains dengue fever [41]. The CDC has piloted 
many of their activities in Battambang Province, which has allowed them to be able to digitize 
their surveillance reports, including dengue fever, in many districts [27]. This has allowed the 
NDCP to collect more accurate dengue fever data from the province.  
The LISA maps, Figures 8 and 9, show similar results to the Local Gi* maps, but reveals 
potential spatial outliers as well. The outliers vary from year to year. These districts either have 
low values surrounded by high values or high values surrounded by low values. These are 
districts that would need further analysis done to determine if surveillance differed that year, if 
there was an increase of traffic or if some other occurrence could have caused either the high or 
low values compared to the neighboring districts. 
5.1 LIMITATIONS 
A limitation of this study was the use of secondary data for analysis. The data was 
provided by the NDCP, who handles the national surveillance of dengue fever in Cambodia. 
Studies have demonstrated that the national surveillance system potentially underreports due to 
only documenting hospitalized cases of dengue fever [3, 14, 42]. This underreporting could have 
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an effect on the analysis of clustering and LISA hot spots, causing a misrepresentation of what 
areas of the country are most affected by dengue fever.  
Additionally, as stated before, sentinel surveillance sites are most likely representing the 
majority of clusters of dengue fever. This data may not be representative of the entire country 
because of the two types of surveillance used to collect dengue cases in Cambodia. This study 
asked where the most cases of dengue fever in Cambodia are and did not take into account 
population density. Accounting for population and performing this analysis with incidence rates, 
instead of counts, could give a clearer picture of dengue fever in Cambodia.   
5.2 FUTURE DIRECTIONS 
Future directions for this study would include performing the analysis with incidence 
rates, instead of counts of dengue cases. Analyzing additional variables, such as rainfall totals or 
vector populations, could also be performed to give a more specific representation of dengue 
fever in Cambodia.  
In order to reduce underreporting issues, which could affect all analyses on dengue in the 
country, sentinel surveillance activities should be expanded. Community-based surveillance has 
been found to be effective and requires little resources [43, 44]. 
Additional studies should be done that includes Thailand, Laos and Vietnam in order to 
compare incidence along borders and to determine transmission patterns between the countries.  
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6.0  CONCLUSION 
Dengue fever has reemerged as a serious public health issue worldwide. Approximately 
two fifths of world’s population is at risk of contracting the virus and it is considered endemic in 
more than 100 countries. The majority of the dengue burden lies in Asia Pacific countries [6]. 
Cambodia has a large dengue burden, with 10,000-40,000 hospitalized cases per year for 
children less than 15 years of age [31]. As dengue fever continues to grow as a public health 
issue worldwide, the need for more effective control and prevention programs becomes more 
important.  
This study examined eleven years, from 2002 to 2012, of national dengue fever 
surveillance data from Cambodia for geospatial patterns to determine where control and 
prevention programs should be targeted. A LISA and Local Gi* analysis of each year revealed 
that districts within Phnom Penh city and Siem Reap Province were consistently hot spots for 
dengue fever. Prevention and education programs should be targeted to these areas. 
Unexpectedly, Battambang and Banteay Meanchey Provinces had significant hot spots nine out 
of the eleven years analyzed. As human movements have been shown to possibly affect dengue 
fever transmission, these results could be due to traffic between Siem Reap and Battambang, 
both of which are heavily populated and transport centers for the rest of the country.  
Further analyses and studies should be done for these data, as other variables, such as 
population, rainfall or vector population, could affect the geospatial patterns of dengue fever in 
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Cambodia. Given the hot spots of dengue found in this study corresponded with multiple sentinel 
surveillance sites, expanding this surveillance could potentially give a clearer picture of dengue 
patterns in the country. 
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APPENDIX: MAPS 
Figure 4. Sentinel Surveillance Sites 
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 Figure 5. Local Gi* and Significance Maps 2002-2005 
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Figure 6. Local Gi* and Significance Maps 2006-2009 
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Figure 7. Local Gi* and Significance Maps 2010-2012 
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 Figure 8. LISA Maps 2002-2007 
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Figure 9. LISA Maps 2008-2012 
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